Recent events
Recent events tied to this brand in public sources.
Back to profile11 entries
2026
Danaher reports quarterly earnings
Danaher announced quarterly earnings results on Tuesday, reporting earnings per share of $2.11, which beat the consensus estimate of $1.92 by $0.19.
2026
Anthropic launches Model Hardware Standard (MHS) for AI agents to control physical hardware
Anthropic announced the Model Hardware Standard (MHS), a new standard that lets large-model-driven AI agents such as Claude safely and quickly operate physical devices including microscopes, robotic arms, liquid handlers and lasers. MHS was developed from a collaboration with the Howard Hughes Medical Institute (HHMI) Janelia Research Campus and is available as a research preview to a first group of research labs and advanced manufacturers. Hardware and software vendors including AWS, Automata, Danaher, Doosan Robotics, MBF Bioscience, QIAGEN, Tecan, Universal Robots, Hugging Face and Raspberry Pi are adding or testing MHS support.
2026
Genedata launches Biomarker Discovery Agent in Genedata Profiler
Genedata, a Danaher company, announced a new AI agent in Genedata Profiler, its enterprise platform for integrating and analyzing translational and clinical research data, expanding AI-driven biomarker discovery capabilities. In collaboration with Washington University School of Medicine in St. Louis, the agent was used to identify a five-protein blood-based model for Alzheimer's disease validated in an independent cohort.
2021
Danaher globally launches medical-device UDI solution
Danaher's product identification platform completed the global launch of its medical-device Unique Device Identification (UDI) solution at the China International Import Expo.
2021
Danaher completes acquisition of Aldevron
Danaher Corporation announced completion of its acquisition of Aldevron. Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
2021
Danaher announces planned acquisition of Aldevron
Danaher announced a definitive agreement to acquire Aldevron for $9.6 billion. The transaction was subject to customary conditions, including regulatory approvals.
2020
Danaher appoints Rainer M. Blair president and CEO
Danaher appointed Rainer M. Blair as president and chief executive officer and as a member of its board, effective September 1, 2020. His predecessor, Thomas P. Joyce, Jr., retired from those positions.
2020
Danaher announces Rainer Blair as CEO successor
Danaher announced that Executive Vice President Rainer Blair would succeed Thomas Joyce Jr. as President and Chief Executive Officer effective September 1. Blair was also set to join the board, while Joyce would continue as a senior advisor through February 28, 2021.
2020
Danaher completes acquisition of GE Life Sciences’ biopharma business
Danaher announced that it had completed its acquisition of the biopharma business from General Electric Company’s Life Sciences division. The acquired business will operate as a standalone company within Danaher’s Life Sciences segment.
2019
Danaher prices $4 billion senior notes offering
Danaher announced that its wholly owned subsidiary priced a senior notes offering totaling $4 billion; the company anticipated using net proceeds to fund part of its acquisition of GE Life Sciences' Biopharma Business and related costs.
2019
Danaher announces sale of life sciences businesses to Sartorius
Danaher announced that it had signed an agreement to sell certain life sciences businesses to Sartorius AG for $750 million. The businesses include biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards.